Menon Adapting NMR-based Biothreat Detection Technology for Entry into MDx Space | GenomeWeb

NEW YORK (GenomeWeb News) – For the past eight years Menon Biosensors has operated in near secrecy developing a technology with US government backing to detect some of the world's deadliest biothreat pathogens.

Now, the San Diego-based firm is preparing to use that same technology to change the healthcare market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.